Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Leverages Genetic Technology to Produce First-In-Class Medical Grade Cannabis

  • Science continues to substantiate use of cannabis for pain relief, epileptic seizure control
  • Research suggests strains with optimized cannabinoid profiles are more effective 
  • PACR produces premium top-quality strains cultivated using genetics-first approach to optimize cannabinoid profiles
  • Genetic cultivation techniques allow selection for specific growing environments, maximum yields 

With a growing list of use cases spanning pain relief to seizure control, the medicinal use of cannabis goes back thousands of years ( Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), a Canadian cannabis company, leverages a genetics-focused approach to producing premium-quality strains with optimum cannabinoid profiles that are prized among consumers, including those in the hyper-growth medicinal space. 

Recent studies suggest that tetrahydrocannabinol (“THC”) and cannabidiol (“CBD”), along with hundreds of other potentially active compounds, can help relieve pain and control seizures. Referred to as “full-spectrum” cannabis, these specialized strains with optimized profiles were shown to be more effective due to the synergistic effect between specific cannabinoids and terpenes, organic compounds that enhance the effect of cannabis. 

Pac Roots leverages high-end genetics and specialized cultivars to produce distinctive cannabis products, specifically strains that can be tailored for medicinal purposes. This is made possible through Pac Roots’ exclusive partnership with Phenome One, a plant breeding management and analytics firm that gives the Company access to one of the largest live genetic libraries in Canada. 

Through Phenome One’s platform, Pac Roots has access to a massive database detailing over 350 unique laboratory-analyzed and rigorously field-tested cannabis cultivars that support each stage of the breeding process. Supported by data going back over 30 years, Pac Roots is also able to produce top-quality anti-fungal strains that are bred to thrive in specific climates – including the Fraser Valley in British Columbia where the Company recently made a sizeable land purchase.

With its high-quality soil and favorable climate, the Fraser Valley Regional District is known worldwide as one of Canada’s most productive and intensively farmed areas. Pac Roots recently made the strategic purchase through a share purchase agreement that gave the Company outright ownership of 250 acres of land spread over nine parcels. 

“The addition of such a substantial package of land to our portfolio is a major step for PacRoots. We are pleased to have the opportunity to add significant acreage with an acquisitional cost base of $9,600 per acre,” said Pac Roots President and CEO Patrick Elliott ( “This land has no zoning restrictions and is not situated within the Agricultural Land Reserve, which provides for infinite development possibilities.”

Medicinal cannabis products are growing in popularity across all demographics because of increased consumer awareness and the growing body of scientific evidence. As consumer demand for medicinal cannabis increases, the ability to deliver top-quality strains with optimized cannabinoid profiles is growing in importance. Pac Roots’ novel genetics-based approach to producing premium-grade cannabis, along with its portfolio of pristine land and production assets, is positioning the company favorably as a leader in the rapidly growing industry. 

For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at 

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.


Select A Month

CBDWire Currently Accepts



Bitcoin Cash

Bitcoin Cash

Doge Coin






USD Coin

USD Coin

Contact us: 303.498.7722